Filter Results:
(151)
Show Results For
- All HBS Web
(1,278)
- People (5)
- News (151)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
Show Results For
- All HBS Web
(1,278)
- People (5)
- News (151)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
Sort by
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
pharmaceuticals are the primary choice,” says Bennet. “But in most cases they’re not really a miracle” but a temporary reprieve. Bennet notes that while millions of patients suffer from psychiatric disorders, many don’t know that deep... View Details
Keywords: Janelle Nanos
- 01 Jun 2023
- News
Research Brief: The Best Medicine
As it turns out, innovation doesn’t benefit everyone equally, and a new study tries to understand how that plays out in the pharmaceutical R&D process in the United States. “The numbers are striking,” says Associate Professor Joshua... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
told the Daily Mail. In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and pharmaceutical... View Details
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
dating—all those things—to life in a way that consumers have never experienced before?’” “Julie is a content-first pharmaceutical company; we exist to help bridge the consumer’s understanding of how her body works and how these medicines... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on drug price growth. Today,... View Details
- 24 Oct 2016
- News
Health Care Pioneer Giusti Named McCance Senior Fellow at HBS
care, or engineering. Giusti currently serves as faculty cochair of the HBS-Kraft Precision Medicine Accelerator. She has more than two decades of experience in the pharmaceutical industry, having previously held senior positions at G. D.... View Details
Keywords: Susan Young
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the Multiple Myeloma Research... View Details
- 06 Mar 2018
- News
A Voice for Diversity and Impact at Scale
its Pharmaceutical and Medical Products Practice in Europe, the Middle East, and Africa. And as a member of the global board of directors, she has spearheaded flagship research linking diversity to performance, championing the notion that... View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
self-cleaning rat cages for psychology labs. Learning that pharmaceutical companies use large quantities of rats, they negotiated a deal with him and over the next few months also executed a roll-up strategy that eventually made them the... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
headlines, the vaccine sector was a pretty sleepy space. Interest in vaccine development and production had been on the decline for decades. In the 1960s—the triumphant years after Jonas Salk discovered the first polio vaccine—there were 26 View Details
- 03 Dec 2024
- News
From One to Many
created with Ferrazzi Greenlight? When I went to HBS I was known as the guy who came out of manufacturing, having spent a number of years implementing Total Quality Management at a pharmaceutical company in Wilmington, Delaware. I reached... View Details
- 01 Oct 1998
- News
Going Against the Flow
500 automobile, chemical, and pharmaceutical companies that actually run businesses here. Those latter companies know the market and have done very well as a result. "If you're going to invest in emerging markets," he continues, "you also... View Details
Keywords: Dun Gifford, Jr.
- 01 Mar 2012
- News
How to Close the Health Gap
real progress has been made over the last decade, thanks in part to funding from organizations such as the Bill & Melinda Gates Foundation and efforts by pharmaceutical companies and governments to make drugs available at little or no... View Details
- 01 Mar 2003
- News
Naina Lal Kidwai
to the global automobile industry. Biotechnology and pharmaceutical firms are emerging as international players. There are also opportunities in infrastructure investment, such as telecom, ports, roads, and airports. Please comment on... View Details
- 01 Sep 2006
- News
HBS Student Battles ALS
people every year, is not a high priority for either the public or pharmaceutical companies. To stimulate novel treatment ideas and to raise the venture funding needed to get those ideas to market, he launched two organizations. One is... View Details